Earlier, Australia signed an agreement to acquire ten million doses of the Pfizer vaccine. Credit: x3 from Pixabay.

Norway has raised concerns about Pfizer’s Covid-19 vaccine safety after 29 elderly people with serious underlying health conditions have died after receiving the shot.

Bloomberg noted that even though it is not clear when the deaths happened, the country has inoculated as many as 42,000 individuals and concentrated on those at higher risk of contracting Covid-19, which includes the elderly.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The media company quoted the Norwegian Medicines Agency as saying in a written response that until 15 January, only Pfizer’s vaccine was available in Norway, and “all deaths are thus linked to this vaccine.”

The agency added: “There are 13 deaths that have been assessed, and we are aware of another 16 deaths that are currently being assessed. All the reported deaths related to ‘elderly people with serious basic disorders’.”

Norway Health Minister Greg Hunt told reporters in Melbourne that Australia is waiting for critical information on this issue from Pfizer, health authorities, as well as from the government.

Earlier, the country signed an agreement to acquire ten million doses of the vaccine.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Last December, the US Food and Drug Administration (FDA) started investigating around five allergic reactions that occurred after individuals received Pfizer and BioNTech’ Covid-19 shot in the country.

Meanwhile, Pfizer is set to cut the supply of its vaccine to Europe for a brief period to advance its production capacity, the company and the Norwegian Institute of Public Health (FHI) noted.

In a separate development, Jubilant Therapeutics is partnering with The Wistar Institute to analyse the ability of Peptidyl Arginine Deiminase 4 (PAD4) inhibitors to inhibit neutrophil extracellular trap (NET) formation in Covid-19-related cytokine storms.